327 related articles for article (PubMed ID: 6391784)
1. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
[TBL] [Abstract][Full Text] [Related]
2. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
Owens NJ; Schauer AR; Nightingale CH; Golub GR; Martin RS; Williams HM; Schauer PK
Clin Pharm; 1984; 3(2):167-70. PubMed ID: 6373102
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
4. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents.
Braude D; Soliz T; Crandall C; Hendey G; Andrews J; Weichenthal L
Am J Emerg Med; 2006 Mar; 24(2):177-82. PubMed ID: 16490647
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapy.
Smaglia RA; Parkinson DR; Taylor CD
Clin Pharm; 1984; 3(1):68-71. PubMed ID: 6365417
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
[TBL] [Abstract][Full Text] [Related]
7. [Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy].
Fujii M; Kiura K; Tamai M; Okabe K; Toki H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2562-7. PubMed ID: 3527070
[TBL] [Abstract][Full Text] [Related]
8. [Antiemetic effects of combinations of metoclopramide, droperidol and dexamethasone for the prevention of cisplatin-induced gastro-intestinal toxicity: a randomized crossover trial].
Fujii M; Kiura K; Kamei H; Okabe K; Toki H
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2257-61. PubMed ID: 3300561
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
[TBL] [Abstract][Full Text] [Related]
10. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
[TBL] [Abstract][Full Text] [Related]
11. Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
Agostinucci WA; Gannon RH; Golub GR; Martin RS; Schauer PK; Dinonno EB
Clin Pharm; 1988 Jun; 7(6):454-7. PubMed ID: 3402181
[TBL] [Abstract][Full Text] [Related]
12. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Gilbert CJ; Ohly KV; Rosner G; Peters WP
Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
[TBL] [Abstract][Full Text] [Related]
14. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD
Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.
Carr BI; Bertrand M; Browning S; Doroshow JH; Presant C; Pulone B; Hill LR
J Clin Oncol; 1985 Aug; 3(8):1127-32. PubMed ID: 4040552
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of droperidol, metoclopramide, propofol, and ondansetron for the prevention of nausea and vomiting following middle ear surgery].
Karlidağ T; Kaygusuz I; Bestaş A; Keleş E; Demirbağ E; Yalçin S
Kulak Burun Bogaz Ihtis Derg; 2002; 9(5):331-6. PubMed ID: 12471278
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
Saller R; Hellenbrecht D
Cancer Treat Rep; 1985 Nov; 69(11):1301-3. PubMed ID: 3912040
[TBL] [Abstract][Full Text] [Related]
18. Comparison of metoclopramide, prochlorperazine and placebo in prevention of postoperative nausea and vomiting (PONV) following tonsillectomy in young adults.
Jamil M; Gilani SM; Khan SA
J Ayub Med Coll Abbottabad; 2005; 17(4):40-4. PubMed ID: 16599033
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin].
Martín M; Díaz-Rubio E
Med Clin (Barc); 1989 Jun; 93(2):50-3. PubMed ID: 2755259
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of droperidol in the prevention of cisplatin-induced delayed emesis: a double-blind, randomised parallel study.
Minegishi Y; Ohmatsu H; Miyamoto T; Niho S; Goto K; Kubota K; Kakinuma R; Kudoh S; Nishiwaki Y
Eur J Cancer; 2004 May; 40(8):1188-92. PubMed ID: 15110882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
